Second-Generation Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia OncLive 5:34 10 years ago 1 006 Скачать Далее
Second-generation tyrosine kinase inhibitors for chronic myeloid leukemia VJHemOnc – Video Journal of Hematology & HemOnc 3:12 9 years ago 626 Скачать Далее
Selecting a Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia Case Study OncLive 9:08 8 years ago 920 Скачать Далее
Chronic Myeloid Leukemia (CML) - Treatment - Tyrosine Kinase (TK) Inhibitors Medicosis Perfectionalis 4:42 5 years ago 59 286 Скачать Далее
Optimizing discontinuation of tyrosine kinase inhibitor treatment for chronic myeloid leukemia VJHemOnc – Video Journal of Hematology & HemOnc 4:33 9 years ago 476 Скачать Далее
Dr. Erba on Treating Chronic Phase CML with Second-Generation TKIs Targeted Oncology 1:53 11 years ago 102 Скачать Далее
Benefits of second generation TKIs for CML in the frontline VJHemOnc – Video Journal of Hematology & HemOnc 1:46 5 years ago 72 Скачать Далее
Ponatinib in chronic-phase CML patients with prior second generation TKI exposure VJHemOnc – Video Journal of Hematology & HemOnc 4:44 3 years ago 309 Скачать Далее
Adverse Events of Second-Generation TKIs Used in Treating CML Targeted Oncology 5:57 4 years ago 35 Скачать Далее
Treating the Newly Diagnosed Patient With Chronic Myeloid Leukemia OncLive 10:40 9 years ago 3 840 Скачать Далее
Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia ecancer 6:08 9 years ago 352 Скачать Далее
Update on the efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukemia VJHemOnc – Video Journal of Hematology & HemOnc 2:03 9 years ago 168 Скачать Далее
Comparing Frontline Therapies for the Treatment of Chronic Myeloid Leukemia Targeted Oncology 1:59 4 years ago 199 Скачать Далее
What is the best treatment in the next few years to achieve more treatment-free remission in CML? VJHemOnc – Video Journal of Hematology & HemOnc 4:13 7 years ago 906 Скачать Далее
